Ultragenyx Pharmaceutical... (RARE)
NASDAQ: RARE
· Real-Time Price · USD
29.68
0.67 (2.31%)
At close: Aug 15, 2025, 3:59 PM
29.87
0.62%
After-hours: Aug 15, 2025, 07:57 PM EDT
13F Institute Ownership
Total Institutes of 318 in Ultragenyx Pharmaceutical reduced their positions with a decrease of 15 investors compared to the previous quarter. A reduction of 372.72K shares, as total invested capital declined by $524.4M with ownership percentage dropping from 91.63% to 90.48%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 0.969
0.97
Call Flow 1,069,100
51%
Put Flow 1,035,700
49%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 10.38% | 10M | -0.39% | 361.96M | < 0.01% | May 09, 2025 |
| Blackrock, Inc. | 6.40% | 6.16M | -5.79% | 222.99M | < 0.01% | May 02, 2025 |
| Sands Capital Management, LLC | 4.32% | 4.16M | -3.13% | 150.76M | 0.51% | May 14, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.